Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
1 - 10 out of 16Page size: 10
  1. 2017
  2. Published

    Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

    Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, Seliger, B., Jönsson, G. & Svane, Inge Marie, 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

    Ascierto, P. A., Del Vecchio, M., Robert, C., Mackiewicz, A., Chiarion-Sileni, V., Arance, A., Lebbé, C., Bastholt, L., Hamid, O., Rutkowski, P., McNeil, C., Garbe, C., Loquai, C., Dreno, B., Thomas, L., Grob, J-J., Liszkay, G., Nyakas, M., Gutzmer, R., Pikiel, J. & 10 others, Grange, F., Hoeller, C., Ferraresi, V., Smylie, M., Schadendorf, D., Mortier, L., Svane, Inge Marie, Hennicken, D., Qureshi, A. & Maio, M., May 2017, In: Lancet Oncology. 18, 5, p. 611-622 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

    Kongsted, P., Borch, T. H., Ellebaek, E., Iversen, T. Z., Andersen, R., Met, Özcan, Hansen, M., Lindberg, H., Sengeløv, L. & Svane, Inge Marie, 1 Apr 2017, In: Cytotherapy. 19, 4, p. 500-513 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Cancer immunotherapy in patients with preexisting autoimmune disorders

    dqp123, dqp123, Pedersen, M. & Svane, Inge Marie, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 333-337 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H. & Sengeløv, L., Apr 2017, In: Clinical Genitourinary Cancer. 15, 2, p. e281-e287

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model

    Jespersen, H., Lindberg, M. F., dqp123, dqp123, Söderberg, E. M. V., Andersen, R., Keller, U., Ny, L., Svane, Inge Marie, Nilsson, L. M. & Nilsson, J. A., 2017, In: Nature Communications. 8, 10 p., 707.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Immunterapi er kræftbehandling med en helt ny bivirkningsprofil

    Kondrup, M., Raunkilde, L., Svane, Inge Marie, Schmidt, H. & Bastholt, L., 2017, In: Ugeskrift for Laeger. 179, 5 p., V05170365.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

    Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, 2017, In: Stem Cell Investigation. 4, 13 p., 77.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

    Bjoern, J., Lyngaa, R., Andersen, R., Hølmich, Lisbet Rosenkrantz, Hadrup, S. R., dqp123, dqp123 & Svane, Inge Marie, 2017, In: OncoTarget. 8, 16, p. 27062-27074

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

    Lauss, M., dqp123, dqp123, Harbst, K., Andersen, R., Mitra, S., Rosengren, F., Salim, M., Vallon-Christersson, J., Törngren, T., Kvist, A., Ringnér, M., Svane, Inge Marie & Jönsson, G., 2017, In: Nature Communications. 8, 11 p., 1738.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 4054758